Great West Life Assurance CO Clovis Oncology, Inc. Transaction History

Great West Life Assurance CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.63 - $2.96 $3,001 - $14,104	-4,765 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$4.82 - $7.72 $1.57 Million - $2.51 Million	-325,735 Reduced 98.56%	4,765 $27,000
Q3 2020 Nov 13, 2020	BUY	$4.82 - $7.72 $1.57 Million - $2.51 Million	325,735 Added 6835.99%	330,500 $1.93 Million
Q2 2020 Aug 17, 2020	BUY	$5.69 - $9.69 $27,112 - $46,172	4,765 New	4,765 $32,000
Q3 2019 Oct 25, 2019	SELL	$3.93 - $15.35 $27,643 - $107,971	-7,034 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$11.63 - $32.67 $28,947 - $81,315	2,489 Added 54.76%	7,034 $122,000
Q1 2018 May 10, 2018	SELL	$50.12 - $67.72 $93,173 - $125,891	-1,859 Reduced 29.03%	4,545 $240,000
Q4 2017 Feb 09, 2018	BUY	$57.69 - $84.58 $78,804 - $115,536	1,366 Added 27.11%	6,404 $435,000
Q3 2017 Nov 09, 2017	BUY	$67.17 - $84.81 $338,402 - $427,272	5,038	5,038 $403,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.